Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06311721
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-03-08
Brief Title:
A Study to Compare ABP 234 and Keytruda Pembrolizumab in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
Sponsor:
Amgen
Organization:
Amgen
Organization Data
Organization:
Amgen
Class:
INDUSTRY
Study ID:
20210033
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amgen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None